Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 2
1987 2
1988 1
1989 3
1990 9
1991 2
1992 1
1993 2
1994 1
1996 2
1997 1
1998 2
1999 10
2000 4
2001 6
2002 1
2003 2
2004 2
2005 3
2006 1
2007 3
2008 5
2009 4
2010 3
2011 4
2012 4
2013 1
2014 7
2015 5
2016 3
2017 3
2018 14
2019 15
2020 15
2021 8
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 36896478

137 results

Results by year

Filters applied: . Clear all
Page 1
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.
Kopmar NE, Gooley T, Curley N, Russell K, Shaw C, Schonhoff K, Lim J, Halpern AB, Walter RB, Scott BL, Appelbaum J, Hendrie PC, Estey EH, Percival MM. Kopmar NE, et al. Leuk Lymphoma. 2023 May;64(5):1057-1059. doi: 10.1080/10428194.2023.2185087. Epub 2023 Mar 9. Leuk Lymphoma. 2023. PMID: 36896478 Clinical Trial. No abstract available.
Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
Hiddemann W, Aul HC, Maschmeyer G, Urbanitz D, Lathan B, Reichle A, Köppler H, Donhuijsen-Ant R, Ludwig WD, Grüneisen T, et al. Hiddemann W, et al. Haematol Blood Transfus. 1990;33:604-10. doi: 10.1007/978-3-642-74643-7_110. Haematol Blood Transfus. 1990. PMID: 2182450 Clinical Trial. No abstract available.
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
Karp JE, Passaniti A, Gojo I, Kaufmann S, Bible K, Garimella TS, Greer J, Briel J, Smith BD, Gore SD, Tidwell ML, Ross DD, Wright JJ, Colevas AD, Bauer KS. Karp JE, et al. Clin Cancer Res. 2005 Dec 1;11(23):8403-12. doi: 10.1158/1078-0432.CCR-05-1201. Clin Cancer Res. 2005. PMID: 16322302 Clinical Trial.
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia.
Abboud R, Chendamarai E, Rettig MP, Trinkaus KM, Riedell PA, Abboud CN, Ghobadi A, Pusic I, Stockerl-Goldstein K, Schroeder MA, Vij R, Westervelt P, DiPersio JF, Uy GL. Abboud R, et al. Haematologica. 2020 Aug;105(8):e404-e407. doi: 10.3324/haematol.2019.236810. Epub 2019 Nov 21. Haematologica. 2020. PMID: 31753931 Free PMC article. Clinical Trial. No abstract available.
137 results